-
-
[1] Reiter RE, Gu Z, Watabe T, et al. Prostate stem cell antigen:a cell surface marker overexpressed in prostate cancer[J]. Proc Natl Acad Sci USA, 1998, 95:1735-1740. http://onlinelibrary.wiley.com/resolve/reference/PMED?id=9465086 [2] Barbisan F, Mazzucchelli R, Santinelli A, et al. Expression of prostate stem cell antigen in high-grade prostatic intraepithelial neoplasia and prostate cancer[J]. Histopathology, 2010, 57:572-579. http://d.wanfangdata.com.cn/periodical/a7339dff9f7eb3fbb046db5a5d7f6db7 [3] Elsamman E, Fukumori T, Kasai T, et al. Prostate stem cell antigen predicts tumour recurrence in superficial transitional cell carcinoma of the urinary bladder[J]. BJU Int, 2006, 97:1202-1207. doi: 10.1111/j.1464-410X.2006.06153.x/epdf [4] 杨文彬, 蔡锋, 程传涛, 等.人胰腺癌中前列腺干细胞抗原及紧密连接蛋白-4的表达[J].中国医学科学院学报, 2008, 30:728-731. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgyxkxyxb200806020 [5] Elsamman EM, Fukumori T, Tanimoto S, et al. The expression of prostate stem cell antigen in human clear cell renal cell carcinoma:a quantitative reverse transcriptase-polymerase chain reaction analysis[J]. BJU Int, 2006, 98:668-673. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=10.1191/096032799678847096 [6] Feng HC, Tsao SW, Ngan HY, et al. Overexpression of prostate stem cell antigen is associated with gestational trophoblastic neoplasia[J]. Histopathology, 2008, 52:167-174. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=10.1111/j.1365-2559.2007.02925.x [7] Gu Z, Yamashiro J, Kono E, et al. Anti-prostate stem cell antigen monoclonal antibody 1G8 induces cell death in vitro and inhibits tumor growth in vivo via a Fc-independent mechanism[J]. Cancer Res, 2005, 65:9495-9500. [8] Saeki N, Gu J, Yoshida T, et al. Prostate stem cell antigen:a Jekyll and Hyde molecule?[J]. Clin Cancer Res, 2010, 16:3533-3538. http://www.tandfonline.com/servlet/linkout?suffix=CIT0017&dbid=16&doi=10.3109%2F00365599.2012.756929&key=10.1158%2F1078-0432.CCR-09-3169 [9] 单玉喜, 陶伟, 王文熲, 等.抗前列腺干细胞抗原单克隆抗体制备及治疗鼠前列腺癌移植瘤的实验观察[J].中华泌尿外科杂志, 2006, 27(z1):56-58. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhmnwk2006z1017 [10] Antonarakis ES, Carducci MA, Eisenberger MA, et al. Phase I rapid dose-escalation study of AGS-1C4D4, a human anti-PSCA (prostate stem cell antigen) monoclonal antibody, in patients with castration-resistant prostate cancer:a PCCTC trial[J]. Cancer Chemother Pharmacol, 2012, 69:763-771. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586214 [11] Krupa M, Canamero M, Gomez CE, et al. Immunization with recombinant DNA and modified vaccinia virus Ankara (MVA) vectors delivering PSCA and STEAP1 antigens inhibits prostate cancer progression[J]. Vaccine, 2011, 29:1504-1513. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=388bf2737de2db5bd67715a66290f76a [12] Garcia-Hernandez ML, Gray A, Hubby B, et al. Prostate stem cell antigen vaccination induces a long-term protective immune response against prostate cancer in the absence of autoimmunity[J]. Cancer Res, 2008, 68:861-869. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=7690d1b9853ba390563f685d73275995 [13] Zhang K, Yang F, Ye J, et al. A novel DNA/peptide combined vaccine induces PSCA-specific cytotoxic T-lymphocyte responses and suppresses tumor growth in experimental prostate cancer[J]. Urology, 2012, 79:1410, e7-1410, e13. [14] Xiao L, Joo KI, Lim M, et al. Dendritic cell-directed vaccination with a lentivector encoding PSCA for prostate cancer in mice[J]. PLoS One, 2012, 7:e48866. [15] Hall SJ, Klotz L, Pantuck AJ, et al. Integrated safety data from 4 randomized, double-blind, controlled trials of autologous cellular immunotherapy with sipuleucel-T in patients with prostate cancer[J]. J Urol, 2011, 186:877-881. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=0c9f30750dcdbbc8e161d22e51c58e55 [16] Olafsen T, Gu Z, Sherman MA, et al. Targeting, imaging, and therapy using a humanized antiprostate stem cell antigen (PSCA) antibody[J]. J Immunother, 2007, 30:396-405. http://europepmc.org/abstract/MED/17457214 [17] Kohaar I, Porter-Gill P, Lenz P, et al. Genetic variant as a selection marker for anti-prostate stem cell antigen immunotherapy of bladder cancer[J]. J Natl Cancer Inst, 2013, 105:69-73. http://jnci.oxfordjournals.org/content/105/1/69 [18] Wente MN, Jain A, Kono E, et al. Prostate stem cell antigen is a putative target for immunotherapy in pancreatic cancer[J]. Pancreas, 2005, 31:119-125. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=WK_LWW2017052520438692 [19] Ono H, Yanagihara K, Sakamoto H, et al. Prostate stem cell antigen gene is expressed in islets of pancreas[J]. Anat Cell Biol, 2012, 45:149-154. http://pubmedcentralcanada.ca/pmcc/articles/PMC3472140/ [20] Tanaka M, Komatsu N, Terakawa N, et al. Increased levels of IgG antibodies against peptides of the prostate stem cell antigen in the plasma of pancreatic cancer patients[J]. Oncol Rep, 2007, 18:161-166. http://europepmc.org/abstract/MED/17549363 [21] Foss CA, Fox JJ, Feldmann G, et al. Radiolabeled anti-claudin 4 and anti-prostate stem cell antigen:initial imaging in experimental models of pancreatic cancer[J]. Mol Imaging, 2007, 6:131-139. http://europepmc.org/abstract/med/17445507
点击查看大图
计量
- 文章访问数: 74
- HTML全文浏览量: 21
- PDF下载量: 1
- 被引次数: 0